前例のない世界的危機下での連続生産方式の採用

Accelerate Complex Molecule Development by Optimizing Chemical Synthesis and Formulation

連続生産は、柔軟性に優れており、バッチ生産に比べ、スケールアップに要するコストを最高1.65倍削減可能な革新的なソリューションです。連続生産のメリットをご紹介します。

原薬使用量の低減
開発期間の短縮
製品の品質と恒常性の向上
工程管理の強化による収率の向上と不合格バッチの削減
総保有コストの削減

各種資料

関連する施設紹介

関連する各種資料

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

Manufacturing Innovation: The Case for Continuous Manufacturing

Navigating Decision Points to Fast-Track Commercialisation

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Oral solid dose - Access a range of flexible drug development & manufacturing solutions

Orphan Drugs: Balancing Financial Incentives & Complex Challenges

Navigating the Adoption of Continuous Manufacturing Amid Unprecedented Global Challenges

Impact of a Pandemic Outbreak on Vaccine Development Approach

Evaluate Impact of Spray Drying Process Parameters and Equipment Type on the Granule Characteristic of the Immediate Release Tablets of a BCS (Biopharmaceutical Classification System) Class–IV Drug

Hot Melt Extrusion Process Optimization and Formulation Development of Amorphous Solid Dispersions for a Poorly Soluble Calcium Channel Blocker

Lyophilization: Small-Large Scale Comparability

To Determine the Dosing Disk and Encapsulation Speed for Encapsulation of a Drug Product Using Automated Encapsulator

A Quality by Design Approach to Optimize Tablet Formulations containing PVP VA64 Amorphous Dispersions: Formulation Variables

Discrete Element Modeling of a Pharmaceutical Blending Process

Accelerated stability assessment for an oral N-type calcium channel blocker

Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product

Enhanced Solubilization of an Analgesic/Antipyretic Drug With The Use of Polymeric Excipients

Controlled Release of an OTC Cough Suppressant in a Soft Gelatin Based Dosage Form

Development of a High Shear Wet Granulation Process Through the Use of Design of Experiments

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Continuous Manufacturing: The Alternative to Batch Manufacturing

Telltale Signs You're with the Wrong CDMO

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Biologics Overview: Flexible Biomanufacturing Solutions

Technology Transfers: Reaping Rewards, Reducing Risks